IsoBED: A tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Bruzzaniti, Vicente ^a   Abate, Armando ^a   Pedrini, Massimo ^a   Benassi, Marcello ^a   Strigari, Lidia ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER PROGRAM; DOSIMETRY; INTENSITY MODULATED RADIATION THERAPY; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION FIELD; ALGORITHM; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER INTERFACE; HUMAN; INFORMATION PROCESSING; METHODOLOGY; NEOPLASM;

ALGORITHMS; AUTOMATIC DATA PROCESSING; DOSE FRACTIONATION; HUMANS; NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; SOFTWARE; SOFTWARE VALIDATION; USER-COMPUTER INTERFACE;

EID: 79955681832     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-52     Document Type: Article

References (39)

1. Concomitant boost radiotherapy in the treatment of head and neck cancer. KK Ang LJ Peters, Semin Radiat Oncol 1992 2 31 33 10.1016/S1053-4296(05)80049-9
2. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. KK Ang LJ Peters RS Weber, Int J Radiat Oncol Biol Phys 1990 19 1339 1345 10.1016/0360-3016(90)90341-G 2262355
3. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. R Mohan Q Wu M Manning R Schmidt-Ullrich, Int J Radiat Oncol Biol Phys 2000 46 3 619 630 10.1016/S0360-3016(99)00438-1 10701741 (Pubitemid 30100639)
4. Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing. N Dogan S King B Emami N Mohideen N Mirkovic LB Leybovich A Sethi, Int J Radiat Oncol Biol Phys 2003 57 1480 1491 10.1016/S0360-3016(03)01569-4 14630288 (Pubitemid 37443991)
5. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. A Fogliata A Bolsi L Cozzi J Bernier, Radiother Oncol 2003 69 267 275 10.1016/j.radonc.2003. 10.003 14644486 (Pubitemid 37486001)
6. A heterogeneous dose distribution in simultaneous integrated boost: the role of the clonogenic cell density on the tumor control probability. L Strigari M D'Andrea A Abate M Benassi, Phys Med Biol 2008 53 5257 5273 10.1088/0031-9155/53/19/001 18758004
7. Prostate IMRT fractionation strategies: two-phase treatment versus simultaneous integrated boost. P Stavrev D Hristov, Radiol Oncol 2003 37 115 126
8. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. R Mohan Q Wu M Manning R Schmidt-Ullrich, Int J Radiat Oncol Biol Phys 2000 46 619 630 10.1016/S0360-3016(99)00438-1 10701741 (Pubitemid 30100639)
9. Tolerance of normal tissue to therapeutic irradiation. B Emami J Lyman A Brown L Coia M Goitein JE Munzenrider B Shank LJ Solin M Wesson, Int J Radiat Oncol Biol Phys 1991 21 109 122 2032882
10. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer. L Strigari G Arcangeli S Arcangeli M Benassi, Int J Radiat Oncol Biol Phys 2009 73 1454 1460 10.1016/j.ijrobp.2008.07.024 18990503
11. Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. S Marzi G Arcangeli B Saracino MG Petrongari V Bruzzaniti G Iaccarino V Landoni A Soriani M Benassi, Int J Radiat Oncol Biol Phys 2007 68 41 49 10.1016/j.ijrobp.2006.12. 003 17276615 (Pubitemid 46589831)
12. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). T Rancati C Fiorino G Gagliardi GM Cattaneo G Sanguineti VC Borca C Cozzarini G Fellin F Foppiano G Girelli L Menegotti A Piazzolla V Vavassori R Valdagni, Radiother Oncol 2004 73 21 32 10.1016/j.radonc.2004.08.013 15465142 (Pubitemid 39304121)
13. Comparison of IMRT planning with two-step and one-step optimization: a strategy for improving therapeutic gain and reducing the integral dose. A Abate MC Pressello M Benassi L Strigari, Phys Med Biol 2009 54 23 7183 98 10.1088/0031-9155/54/23/010 19920309
14. A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy. L Strigari M Benassi G Arcangeli V Bruzzaniti G Giovinazzo L Marucci, Int J Radiat Oncol Biol Phys 2010 77 269 276 10.1016/j.ijrobp.2009.07.1734 20100642
15. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy. S Marzi G Iaccarino K Pasciuti A Soriani M Benassi G Arcangeli G Giovinazzo M Benassi L Marucci, Int J Radiat Oncol Biol Phys 2009 73 1252 1259 10.1016/j.ijrobp.2008.11.020 19251097
16. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. A Eisbruch RK Ten Haken HM Kim LH Marsh JA Ship, Int J Radiat Oncol Biol Phys 1999 45 577 587 10.1016/S0360-3016(99)00247-3 10524409 (Pubitemid 29462636)
17. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. KS Chao JO Deasy J Markman J Haynie CA Perez JA Purdy DA Low, Int J Radiat Oncol Biol Phys 2001 49 907 916 10.1016/S0360-3016(00)01441-3 11240231 (Pubitemid 32184597)
18. Hypofractionated Conformal Radiotherapy (HCRT) for Primary and Metastatic Lung Cancers with Small Dimension. MA Mirri G Arcangeli M Benassi A d'Angelo V Pinzi M Caterino M Rinaldi A Ceribelli L Strigari, Strahlenther Onkol 2009 185 27 33 10.1007/s00066-009-1873-3 19224144
19. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. JC Theuws SL Kwa AC Wagenaar Y Seppenwoolde LJ Boersma EM Damen SH Muller P Baas JV Lebesque, Radiother Oncol 1998 49 233 243 10.1016/S0167-8140(98)00117-0 10075256 (Pubitemid 29067750)
20. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. SL Kwa JV Lebesque JC Theuws LB Marks MT Munley G Bentel D Oetzel U Spahn MV Graham RE Drzymala JA Purdy AS Lichter MK Martel RK Ten Haken, Int J Radiat Oncol Biol Phys 1998 42 1 9 9747813 (Pubitemid 28435589)
21. Use of Normal Tissue Complication Probability Models in the Clinic. Lawrence B Marks Ellen D Yorke Andrew Jackson Randall K Ten Haken Louis S Constine Avraham Eisbruch Søren M Bentzen Jiho Nam Joseph O Deasy, Int J Radiat Oncol Biol Phys 2010 76 3 supplement 1: S10 S19 20171502
22. Poisson formulas for tumor control probability with clonogenic proliferation. J Deasy, Radiat Res 1996 145 382 384 10.2307/3578994 8927706
23. Complication probability as assessed from dose-volume histograms. JT Lyman, Radiat Res Suppl 1985 8 13 19 3867079
24. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. GJ Kutcher C Burman, Int J Radiat Oncol Biol Phys 1989 16 1623 1630 10.1016/0360-3016(89)90972-3 2722599 (Pubitemid 19154353)
25. Fitting of normal tissue tolerance data to an analytic function. C Burman GJ Kutcher B Emami M Goitein, Int J Radiat Oncol Biol Phys 1991 21 123 135 2032883
26. Optimization of uncomplicated control for head and neck tumors. A gren A Brahme I Turesson, Int J Radiat Oncol Biol Phys 1990 19 1077 1085 10.1016/0360-3016(90)90037-K 2211246 (Pubitemid 20345184)
27. Tumour and normal tissue responses to fractionated non-uniform dose delivery. P Kallman A Agren A Brahme, Int J Radiat Biol 1992 62 249 262 10.1080/09553009214552071 1355519
28. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. J Fowler, Acta Oncol 2005 44 265 276 10.1080/02841860410002824 16076699 (Pubitemid 40904130)
29. Is / for prostate tumors really low? JF Fowler RJ Chappell MA Ritter, Int J Radiat Oncol Biol Phys 2001 50 1021 1031 10.1016/S0360-3016(01)01607-8 11429230
30. BIOPLAN: software for the biological evaluation of radiotherapy treatment plans. B Sanchez-Nieto AE Nahum, Med Dosim 2000 25 71 76 10.1016/S0958-3947(00) 00031-5 10856684 (Pubitemid 30336646)
31. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. B Warkentin P Stavrev N Stavreva C Field BG Fallone, J Appl Clin Med Phys 2004 5 50 63 10.1120/jacmp.26.149 15753933
32. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. I El Naqa G Suneja PE Lindsay AJ Hope JR Alaly M Vicic JD Bradley A Apte JO Deasy, Phys Med Biol 2006 51 5719 5735 10.1088/0031-9155/51/22/001 17068361 (Pubitemid 46217664)
33. CERR: a computational environment for radiotherapy research. JO Deasy AI Blanco VH Clark, Med Phys 2003 30 979 985 10.1118/1.1568978 12773007 (Pubitemid 36578702)
34. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy. HA Gay A Niemierko, Phys Med 2007 23 115 125 10.1016/j.ejmp.2007. 07.001 17825595 (Pubitemid 350166992)
35. A computational tool for the efficient analysis of dose-volume histograms for radiation therapy treatment plans. A Pyakuryal WK Myint M Gopalakrishnan S Jang JA Logemann BB Mittal, J Appl Clin Med Phys 2010 11 137 157
36. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT subcommittee of the AAPM radiation therapy committee. GA Ezzell JM Galvin D Low JR Palta I Rosen MB Sharpe P Xia Y Xiao L Xing CX Yu, Med Phys 2003 30 2089 2115 10.1118/1.1591194 12945975 (Pubitemid 37022015)
37. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. B Fraass K Doppke M Hunt G Kutcher G Starkschall R Stern J Van Dyke, Med Phys 1998 25 1773 1829 10.1118/1.598373 9800687 (Pubitemid 28485202)
38. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. C Park L Papiez S Zhang M Story RD Timmerman, Int J Radiat Oncol Biol Phys 2008 70 847 52 10.1016/j.ijrobp.2007.10.059 18262098 (Pubitemid 351199730)
39. Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852. JF Fowler, Int J Radiat Oncol Biol PhysPhys 2008 72 957 10.1016/j.ijrobp.2008.06.1929